Microenergy Medical Technology Co., Ltd, a Hangzhou-based manufacturer of active intervention medical devices, has reportedly secured “tens of millions” of renminbi in a pre-Series A financing round. The funding was led by TigerYeah Capital, with contributions from TriWise Capital and HUAGAI Capital.
Established in 2021, Microenergy Medtech has a presence in Hangzhou and Shenzhen, China, as well as Coburg, Germany. The company specializes in a range of innovative medical devices, including a 355nm solid-state pulse laser vascular ablation system, a differentiated and innovative shockwave balloon system, a varicose vein laser ablation system, and a laser renal artery sympathetic nerve ablation system (RDN). The varicose vein laser ablation system is anticipated to receive its first marketing approval in China by the end of 2024.- Flcube.com
